We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the risk of ovarian cancer after hysterectomy. Learn about symptoms, diagnosis, prevention, and when to seek medical advice, even if your ovaries were removed.
A hysterectomy is a significant surgery, and it's understandable to have questions about its long-term effects, especially concerning cancer risk. Many women believe that having their uterus removed eliminates the risk of ovarian cancer. While it certainly reduces the risk, it doesn't eliminate it entirely. This article explores why and what you can do to stay informed and protected.
A hysterectomy is the surgical removal of the uterus. The reasons for undergoing this procedure vary widely, from fibroids and endometriosis to uterine prolapse and, unfortunately, cancer. It's important to understand that a hysterectomy can be performed in different ways:
Often, during a hysterectomy, the ovaries and fallopian tubes may or may not be removed. The decision to remove them depends on various factors, including your age, menopausal status, family history of cancer, and the reason for the hysterectomy itself.
The ovaries are the primary source of eggs and produce essential hormones like estrogen and progesterone. Ovarian cancer originates from the cells within the ovaries. When a hysterectomy is performed, the uterus is removed. However, if the ovaries are left in place, the risk of developing ovarian cancer persists.
According to the American Cancer Society (ACS), having a hysterectomy, even with the ovaries intact, can reduce the likelihood of developing ovarian cancer by about one-third. This reduction is partly because the surgery itself might alter the pelvic environment or reduce inflammation that could contribute to cancer development.
A more significant reduction in risk occurs when the ovaries and fallopian tubes are also removed during the hysterectomy. This combined procedure is known as a bilateral salpingo-oophorectomy (BSO). When both ovaries are removed, the risk of ovarian cancer drops dramatically.
This is a critical point of confusion for many. Even if both ovaries have been surgically removed, there's still a small possibility of developing a condition that behaves like ovarian cancer. Here's how:
Sometimes, a few ovarian cells can migrate to other parts of the pelvic cavity, such as the peritoneum (the lining of the abdomen), before the ovaries are removed. If these cells were already present and have the potential to become cancerous, they can still develop into cancer, even after the ovaries are gone. This is often referred to as primary peritoneal cancer, which shares many similarities with ovarian cancer in terms of symptoms and treatment.
Furthermore, cancer can originate from cells in the peritoneum itself that are similar to those found in the ovaries. While technically not ovarian cancer, its behavior and treatment are very similar.
Ovarian cancer is a relatively uncommon cancer. The National Cancer Institute (NCI) estimates the lifetime risk for women is about 1.25 percent. However, this risk can be significantly higher for women with specific genetic mutations.
There are different types of ovarian cancer, but the most common is epithelial ovarian cancer, which starts in the cells on the surface of the ovary. Other types can arise from the germ cells (which produce eggs) or stromal cells (which produce hormones).
One of the challenges with ovarian cancer is that its early symptoms can be vague and easily mistaken for other conditions. This often leads to delayed diagnosis. Be aware of persistent or new symptoms, especially if they occur frequently:
Scenario: Priya, a 55-year-old woman who had a hysterectomy five years ago, started experiencing persistent bloating and a feeling of fullness. She initially dismissed it as indigestion. However, the symptoms continued for several weeks, accompanied by mild abdominal discomfort. Concerned, she decided to see her gynecologist.
While any woman with ovaries is at risk, certain factors increase the likelihood:
Diagnosing ovarian cancer, especially after a hysterectomy, requires careful evaluation. Doctors will consider your medical history, symptoms, and perform physical examinations. Diagnostic tools may include:
Treatment for ovarian cancer depends on the type, stage, and your overall health. Common treatment modalities include:
The survival rate for ovarian cancer varies significantly. The 5-year relative survival rate for all stages of epithelial ovarian cancer is about 47 percent. However, when diagnosed and treated in the early stages, the 5-year survival rate can be as high as 92 percent. Unfortunately, only about 20 percent of ovarian cancers are detected at an early stage, highlighting the importance of awareness and prompt medical attention.
While not all cases can be prevented, several strategies can reduce your risk:
It is essential to consult your doctor if you experience any persistent, unusual symptoms, especially those mentioned earlier, even if you have had a hysterectomy. Do not dismiss symptoms like persistent bloating, pelvic pain, or changes in bowel habits. Early detection is key to better outcomes in ovarian cancer.
While the risk is significantly reduced, it's not entirely eliminated. Some ovarian cells might have migrated to the abdominal lining (peritoneum) before the surgery, and these can potentially become cancerous. This is often termed primary peritoneal cancer.
A hysterectomy is the removal of the uterus. A salpingo-oophorectomy is the removal of the fallopian tubes (salpingo-) and ovaries (-oophorectomy). A bilateral salpingo-oophorectomy (BSO) removes both fallopian tubes and both ovaries.
There isn't a single, foolproof screening test for ovarian cancer in the general population, even after a hysterectomy. Doctors rely on symptom assessment, pelvic exams, imaging (like ultrasounds), and sometimes CA-125 blood tests, especially if symptoms arise or if you have a high-risk profile.
The most significant risk factors include a history of BRCA1 or BRCA2 gene mutations, a strong family history of ovarian or breast cancer, increasing age, and never having been pregnant.
If you carry BRCA1 or BRCA2 mutations, you have a significantly higher risk. Discuss options with your doctor, which may include genetic counseling, increased surveillance, and potentially a risk-reducing bilateral salpingo-oophorectomy (preventive removal of ovaries and fallopian tubes) before menopause.
Understand the Urinary Protein Creatinine Ratio (UPCR) test. Learn its importance in diagnosing kidney disease and monitoring treatment.
April 24, 2026
Understand the urinary creatinine test. Learn its purpose, how it's done, and what the results mean for your kidney health.
April 24, 2026
Understand the Total Protein test. Learn why it's vital, what it measures, and what abnormal results might indicate.
April 24, 2026